Twenty equity analysts who rate Medtronic stock have given it an average target price of $87.83, according to Fortune Review and Insights.
Here are three points:
1. The individual targets of the analysts range between $45 and $98.
2. For the current fiscal quarter, analysts expect the company to deliver $1.02 in earnings per share.
3. Medtronic's 50-day moving average is $6.15 and its 200-day moving average is $85.23.